Please complete this follow-up survey to help us measure the impact of our program on your practice. Please share an example of how this program influenced your practice and/or research. Do you believe your participation in this activity has… * DefinitelyVery likelyPossiblyUnlikelyNot at allNA Led to practice improvements Led to practice improvements - Definitely Led to practice improvements - Very likely Led to practice improvements - Possibly Led to practice improvements - Unlikely Led to practice improvements - Not at all Led to practice improvements - NA Led to patient benefits Led to patient benefits - Definitely Led to patient benefits - Very likely Led to patient benefits - Possibly Led to patient benefits - Unlikely Led to patient benefits - Not at all Led to patient benefits - NA What change(s) or improvement(s) have you made to your clinical practice following your participation in this activity? Select all that apply. * Improved recognition of signs and symptoms Improved selection of diagnostic tests Improved interpretation of diagnostic tests Assessing for comorbidities in long-term care Applying appropriate therapies for patients with HPP Avoiding inappropriate therapies for patients with HPP Recognizing need for specialist care This activity confirmed my practice Not in practice Other... What change(s) or improvement(s) have you made to your clinical practice following your participation in this activity? Select all that apply. Other... In which area(s) do you feel your patients have benefited as a result of your participation in this activity? Select all that apply. * Earlier diagnosis More accurate diagnosis Comorbidity prevention Selection of best therapy Referral to appropriate specialist No patient benefit Not in practice Other... In which area(s) do you feel your patients have benefited as a result of your participation in this activity? Select all that apply. Other... Which of the following barriers have prevented you from optimally diagnosing and treating patients with HPP? Select all that apply. * Cost of therapy Difficulty distinguishing features from common bone diseases Difficulty interpreting diagnostic tests Difficulty selecting appropriate tests Inability to prevent disease progression Lack of an approved therapy Lack of clinical guidelines Limited awareness/education of emerging therapies Rarity of HPP in practice No barriers Other... Which of the following barriers have prevented you from optimally diagnosing and treating patients with HPP? Select all that apply. Other... Please share any additional feedback you have about the program. Leave this field blank
